Chembio Diagnostics Inc. buy stratec
Start price
01.04.20
/
50%
€6.55
Target price
04.11.21
€15.00
Performance (%)
-71.76%
End price
05.11.21
€1.85
Summary
This prediction ended on 05.11.21 with a price of €1.85. The BUY prediction by stratec for Chembio Diagnostics Inc. performed very badly with a performance of -71.76%. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Chembio Diagnostics Inc. | - | - | - | - |
iShares Core DAX® | -1.958% | 4.037% | 23.702% | 22.534% |
iShares Nasdaq 100 | 0.272% | 8.670% | 28.181% | 41.859% |
iShares Nikkei 225® | 0.377% | 7.232% | 21.118% | 9.739% |
iShares S&P 500 | 0.370% | 6.511% | 29.221% | 41.850% |
Comments by stratec for this prediction
In the thread Chembio Diagn.new diskutieren
Kantor Fitzgerald erneuert sein Buy-Rating mit $7-Preisziel. Chembio Diagnostik stellt Point-of-Care (POC)-Diagnosetests her, die zur Erkennung oder Diagnose von Krankheiten verwendet werden.
Kursziel geändert auf 15,0
In the thread Trading Chembio Diagn.new
Die von stratec gewählte maximale Laufzeit wurde überschritten